Increases in plasma corticosterone and stretched-attend postures in rats naive and previously exposed to the elevated plus-maze are sensitive to the anxiolytic-like effects of midazolam

Adamec, 2004, Long-lasting, selective, anxiogenic effects of feline predator stress in mice, Physiol. Behav., 83, 401, 10.1016/j.physbeh.2004.08.029 Albrechet-Souza, 2005, A comparative study with two types of elevated plus-maze (transparent vs. opaque walls) on the anxiolytic effects of midazolam, one-trial tolerance and fear-induced analgesia, Prog. Neuro-psychopharmacol. Biol. Psychiatry, 29, 571, 10.1016/j.pnpbp.2005.01.010 Anseloni, 1997, Ethopharmacological analysis of behaviour of rats using variations of the elevated plus-maze, Behav. Pharmacol., 8, 533, 10.1097/00008877-199711000-00011 Anseloni, 1995, Behavioral and pharmacological validation of the elevated plus maze constructed with transparent walls, Braz. J. Med. Biol. Res., 28, 597 Bertoglio, 2000, Previous maze experience required to increase open arms avoidance in rats submitted to the elevated plus-maze model of anxiety, Behav. Brain Res., 108, 197, 10.1016/S0166-4328(99)00148-5 Becker, 1996, Illumination has no effect on rats' behavior in the elevated plus-maze, Physiol. Behav., 59, 1175, 10.1016/0031-9384(95)02224-4 Blanchard, 1993, Defense system psychopharmacology: an ethological approach to the pharmacology of fear and anxiety, Behav. Brain Res., 58, 155, 10.1016/0166-4328(93)90100-5 Calvo-Torrent, 1999, Effect of predatory stress on sucrose intake and behavior on the plus-maze in male mice, Physiol. Behav., 67, 189, 10.1016/S0031-9384(99)00051-7 Carvalho, 2005, Changes in the biogenic amine content of the prefrontal cortex, amygdala, dorsal hippocampus, and nucleus accumbens of rats submitted to single and repeated sessions of the elevated plus-maze test, Braz. J. Med. Biol. Res., 38, 1857, 10.1590/S0100-879X2005001200014 Cole, 1994, Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol, Psychopharmacology, 114, 288, 10.1007/BF02244851 Cruz-Morales, 2002, One-trial tolerance to midazolam is due to enhancement of fear and reduction of anxiolytic-sensitive behaviors in the elevated plus-maze retest in the rat, Pharmacol. Biochem. Behav., 72, 973, 10.1016/S0091-3057(02)00813-4 Dawson, 1994, One-trial tolerance to the effects of chlordiazepoxide on the elevated plus-maze may be due to locomotor habituation, not repeated drug exposure, Psychopharmacology, 113, 570, 10.1007/BF02245242 Dominguez, 2003, Sex differences in serotonergic activity in dorsal and median raphe nucleus, Physiol. Behav., 80, 203, 10.1016/j.physbeh.2003.07.012 Falter, 1992, Resistance of baseline activity in the elevated plus-maze to exogenous influences, Behav. Pharmacol., 3, 123, 10.1097/00008877-199204000-00004 File, 1993, “One trial tolerance” to the anxiolytic actions of benzodiazepine in the elevated plus-maze, or the development of a phobic state?, Psychopharmacology, 110, 240, 10.1007/BF02246980 File, 1994, Raised corticosterone in the rat after exposure to the elevated plus-maze, Psychopharmacology, 113, 543, 10.1007/BF02245237 Genaro, 2004, Social condition affects hormone secretion and exploratory behavior in rats, Braz. J. Med. Biol. Res., 37, 833, 10.1590/S0100-879X2004000600008 Griebel, 1997, Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test, Pharmacol. Biochem. Behav., 57, 817, 10.1016/S0091-3057(96)00402-9 Handley, 1993, 5-HT drugs in animal models of anxiety, Psychopharmacology, 112, 3, 10.1007/BF02247358 Hennessy, 1979, vol. 8, 133 Hogg, 1994, Responders and nonresponders to cat odor do not differ in other tests of anxiety, Pharmacol. Biochem. Behav., 49, 219, 10.1016/0091-3057(94)90479-0 Holmes, 1998, Responses of Swiss-Webster mice to repeated plus-maze experience: further evidence for qualitative shift in emotional state?, Pharmacol. Biochem. Behav., 60, 473, 10.1016/S0091-3057(98)00008-2 Lamberty, 1996, Arm width and brightness modulation of spontaneous behaviour of two strains of mice tested in the elevated plus-maze, Physiol. Behav., 59, 439, 10.1016/0031-9384(96)84912-2 Marin, 2007, Chronic restraint or variable stresses differently affect the behavior, corticosterone secretion and body weight in rats, Physiol. Behav., 90, 29, 10.1016/j.physbeh.2006.08.021 Maisonnette, 1993, Role of resocialization and of 5-HT1A receptor activation on the anxiogenic effects induced by isolation in the elevated plus maze test, Physiol. Behav., 54, 753, 10.1016/0031-9384(93)90087-V Mason, 1968, “Overall” hormonal balance as a key to endocrine organisation, Psychosom. Med., 30, 791, 10.1097/00006842-196809000-00033 Mikics, 2005, Behavioral specificity of non-genomic glucocorticoid effects in rats: effects on risk assessment in the elevated plus-maze and the open-field, Horm. Behav., 48, 152, 10.1016/j.yhbeh.2005.02.002 Pellow, 1985, Validation of open: closed arm entries in the elevated plus-maze as a measure of anxiety in the rat, J. Neurosci. Methods, 14, 149, 10.1016/0165-0270(85)90031-7 Rodgers, 1993, An ethological analysis of chlordiazepoxide and bretazenil (Ro16-6028) in the murine elevated plus-maze, Behav. Pharmacol., 4, 573 Rodgers, 1995, Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety, Pharmacol. Biochem. Behav., 52, 297, 10.1016/0091-3057(95)00138-M Rodgers, 1993, Influence of prior maze experience on behaviour and responses to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice, Psychopharmacology, 113, 237, 10.1007/BF02245704 Rodgers, 1999, Corticosterone response to the plus-maze: high correlation with risk assessment in rats and mice, Physiol. Behav., 68, 47, 10.1016/S0031-9384(99)00140-7 Setem, 1999, Ethopharmacological analysis of 5-HT ligands on the rat elevated plus-maze, Pharmacol. Biochem. Behav., 62, 515, 10.1016/S0091-3057(98)00193-2 Size, 1976, Glucocorticoid regulation of the serotonergic system of the brain, Adv. Biochem. Psychopharmacol., 15, 251 Treit, 1993, Anxiogenic stimuli in the elevated plus-maze, Pharmacol. Biochem. Behav., 44, 463, 10.1016/0091-3057(93)90492-C Vecsei, 1979, Glucocorticoids: cortisol, corticosterone and compounds, 767 Yang, 2006, Central infusion of Ovine CRF (oCRF) potentiates defensive behaviors in CD-1 mice in the Mouse Defense Test Battery (MDTB), Behav. Brain Res., 171, 1, 10.1016/j.bbr.2006.03.013